Trump administration pushes United States at-home kidney care, transplant availability

Trump administration pushes United States at-home kidney care, transplant availability

President Donald Trump signed an executive order directing the government to revamp the nation's care for kidney disease so that more people whose kidneys fail have a chance at early transplants and home dialysis.

Kidney disease is the ninth-leading cause of death in America, costing United States taxpayers $110 billion every year - more than the National Institutes of Health, the Department of Homeland Security and Nasa combined.

With 37,000,000 Americans affected by kidney disease and 720,000 of those with kidney failure, the need could not be greater for patients, families, and caregivers. This visionary initiative, created to improve patient outcomes and generate significant healthcare savings, addresses the critical areas to significantly improve the lives of individuals with chronic kidney disease, kidney failure, and kidney transplants. In addition, more needs to be done to address shortages in home dialysis supplies and any steps taken to encourage increased dialysis supplies would also be welcomed. 96% of people with early kidney disease are unaware they have it. Currently, almost 100,000 Americans are on the waiting list to receive a kidney transplant. KCP's recommendations include incentivizing transplant through performance measurement and standardizing criteria for waitlist placement to eliminate the selection bias for only those patients most likely to have a successful outcome. "Under the president's leadership, we're working to flip that around". Within 30 days of the date of this order, the Secretary shall select a payment model to test innovations in compensation for providers of kidney care services based on kidney patient cost and quality outcomes.

More news: Kanye West Designing Star Wars-inspired Homes For The Poor
More news: AT&T will finally help users effectively block harassing robocalls
More news: CannTrust's cannabis sales put on hold by Health Canada for unlicensed growing

To learn more about DaVita's integrated kidney care programs, visit The selected model shall include options for flexible advance payments for nephrologists to better support their management and coordination of care for patients with kidney disease. The company is the largest provider of kidney care services in the USA and has been a leader in clinical quality and innovation for 20 years.

The measure also will "double the number of transplants available so that people can get the ultimate goal of any kidney patient, which is a new kidney", said Azar. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all.

"For far too long, the most profitable thing in kidney care has been to place a patient on in-center dialysis", she said. The company also operated 241 outpatient dialysis centers in nine countries across the world. The bipartisan Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 (S.1676), introduced by Senators Benjamin Cardin (D-MD) and Roy Blunt (R-MO), will help millions of individuals living with chronic kidney disease and ESRD achieve the quality of life they want and deserve, if passed. The regulation should expand the definition of allowable costs that can be reimbursed under the Reimbursement of Travel and Subsistence Expenses Incurred Toward Living Organ Donation program, raise the limit on the income of donors eligible for reimbursement under the program, allow reimbursement for lost-wage expenses, and provide for reimbursement of child-care and elder-care expenses.

Related Articles